Global Intravenous (IV) Iron Drugs Market Report: 2016 Edition - New Report by Koncept Analytics

DELHI, India - June 10, 2016 - PRLog -- The global I.V. iron drugs market is growing rapidly due to improvement in the quality of treatment outside dialysis, increasing number of dialysis patients, growing number of ERSD patients worldwide and growing ageing population. Moreover, increasing cases of hypertension, rising healthcare expenditure, prevalence of iron deficiency in women, large potential in new therapeutic areas and higher spending on medicine are also supporting the growth of I.V. iron drugs market.

The US and Europe represents key regions for the I.V. iron market. The US is has been steadily increasing over the past couple of years as fueling the spending power of individuals on healthcare and accelerating economic growth.

As per the report "Global I.V. Iron Market: 2016 Edition" by Koncept Analytics, the demand for I.V. iron drugs will be driven by increasing number of dialysis cases, increasing healthcare expenditure, increasing cases of CKD and ERSD, rising ageing population, shift from urban to rural region, prevalence of iron deficiency in women, increasing life expectancy rate, rising medicine expenditure and growing number of ERSD patients. Some of the noteworthy trends and development in I.V. iron drugs market are new product development, introduction of the first generation drugs InFed (iron dextran) and Dexeferrum (iron dextra) and feraccru treatment penetration. However, the growth of this sector is being hindered by emerging anemia management therapies and associated risks.

The report by Koncept Analytics presents an exhaustive study of global, Europe and the US I.V. iron market. A thorough analysis has been conducted on key market players covering their business overview, product portfolio, financial overview and business strategies.

By combining SPSS Inc.'s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.

List of Charts

Global Iron Product Market by Value (2011-2015)
Global Iron Products Market Share by Segment (2015)
Global I.V. Iron Drugs Market by Value (2010-2015)
Global I.V. Iron Drugs Market by Product (2010-2015)
Global I.V. Iron Drugs Market Share by Product (2015)
European I.V. Iron Drug Market by Value (2010-2015)
European I.V. Iron Drug Market by Product (2010-2015)
European I.V. Iron Drug Market Share by Product (2015)
The US I.V. Iron Drug Market by Value (2010-2015)
The US I.V. Iron Drug Market by Product (2010-2015)
The US I.V. Iron Drug Market Share by Product (2015)
The US Non-dialysis I.V. Iron Drug Market Volume (2010-2015)
The US Non-dialysis I.V. Iron Drug Market Share by Product (2015)
Global Dialysis Patient Population (2007-2015E)
Global Dialysis Patients by Type (2014)
Global Health Care Expenditure Per Capita (2007-2015E)
The US Healthcare Expenditure Per Capita (2007-2015E)
Global Ageing Population (2006-2015E)
Global Urban Population (2007-2015E)
Prevalence of Iron Deficiency in Women in the US
The US Female Population (2007-2015E)
Global Life Expectancy Rate (2007-2015E)
Global Spending on Medicines (2010-2020E)
The US Spending on Medicine (2007-2015)
Global ERSD Patients (2009-2020E)
Global Addressable Patients for Feraccru by Underlying Disease - Developed World
Galenica's Net Sales Share by Business Segments (2015)
Galenica's Net Sales Share by Region (2015)
Galenica's Net Sales and Net Profit (2011-2015)
AMAG Pharmaceuticals' Revenue and Net Income (2011-2015)
Allergan Plc.'s Net Sales Business Segment (2015)
Allergan Plc.'s Revenue and Net Income (2011-2015)
Global I.V. Iron Drug Market Forecast (2014-2019E)

List of Tables

Risk Factors for CKD
Emerging Non-Intravenous Therapies for Anemia Management
Comparison between Injectafer® and Venofer®
Summary of Feraccru vs. IV Iron Profile
Dependent & Independent Variables (2011-2015)
Correlation Matrix
Model Summary - Coefficient of Determination
Regression Coefficients Output

Note:  Purchase by Section Also Available

For more Information:

http://www.konceptanalytics.com/Researchreport/global-intravenous-iv-iron-drugs-market-report-2016-edition-10276.aspx

Koncept Analytics

Vikas Gupta

(Business Development Manager)

FFCS-36, Ansal Plaza

Vaishali, Ghaziabad

U.P - 201010

Tele: +91-120-4130959

Mobile: +91-9811715635

Mail ID - vikas@konceptanalytics.com

Koncept Analytics is a market research company. We are in the field of Market Research from last 10 Years. We do research in telecommunication, healthcare, pharmaceutical, financial services, energy, technology, real estate, logistics, food & beverages and media sectors. For more information:

http://www.konceptanalytics.com